IceCure to Exhibit at the 2025 Indian Society of Vascular and Interventional Radiology (ISVIR) Annual Meeting in Kochi, India

IceCure Medical is excited to participate at the 2025 Indian Society of Vascular and Interventional Radiology (ISVIR) Annual Meeting in Kochi, Kerala, from February 6–9, 2025. Visit the IceCure Booth! IceCure’s Regional Sales Executive, Noam Sorek, and International Sales Director, Rafael Kaplan, will be on-site to discuss the benefits of our liquid nitrogen-based ProSense™ Cryoablation […]
IceCure is proud to sponsor the Breast Cryoablation Mini Master Class held during the 2025 Society of Interventional Oncology (SIO) Annual Scientific Meeting on February 1 in Las Vegas

IceCure is a proud sponsor of the Breast Cryoablation Mini Master Class being held on February 1 in conjunction with the Annual Scientific Meeting of the Society of Interventional Oncology in Las Vegas, NV from January 31 – February 3. About the Breast Cryoablation Mini Master Class at SIO Participants in the half-day course […]
Cryoablation Allows the Ultimate De-escalation of Surgical Therapy for Select Breast Cancer Patients

A study showing that cryoablation allows the ultimate de-escalation of surgical therapy for select breast cancer patients.
Assessing the Outcome of Cryoablation Treatment on Different Molecular Subtypes of Low-Grade Breast Cancer

Study assessing the outcome of cryoablation treatment on different molecular subtypes of low-grade breast cancer.
Cryoablation of Primary Breast Cancer in Patients Ineligible for Clinical Trials: A Multiinstitutional Study

Study on the cryoablation of primary breast cancer in patients ineligible for clinical trials: a multi-institutional study.
Cryoablation Therapy for Early-Stage Breast Cancer: Evidence and Rationale

This publication provides a comprehensive evaluation of cryoablation as a non-surgical alternative to traditional breast-conserving surgery for early-stage breast cancer.
Percutaneous Ultrasound-Guided Cryoablation for Early-Stage Primary Breast Cancer: A Follow-Up Study in Japan

The study investigates the long-term outcomes of percutaneous cryoablation (PCA) as a minimally invasive treatment for early-stage breast cancer (ESBC).
Join IceCure Medical at the European Society of Breast Imaging (EUSOBI) Conference 2024 in Lisbon, Portugal

IceCure is thrilled to be back at the 2024 European Society of Breast Imaging Scientific Meeting. Join us at Booth L5 in Lisbon, Portugal from October 3 – 5. Are you planning to attend EUSOBI 2024? Meet with us to learn more about the ProSense™ Cryoablation System for the treatment of fibroadenoma and breast cancer. The […]
Join IceCure at the 2024 Cardiovascular and Interventional Radiology Society of Europe (CIRSE) Conference in Lisbon, Portugal

IceCure is a proud exhibitor at the 2024 Cardiovascular and Interventional Radiology Society of Europe (CIRSE) Conference in Lisbon, Portugal from September 14 – 18. Are you attending CIRSE 2024? Visit us at Booth 15. Complete the contact us form on this page and schedule a meeting with IceCure! IceCure Medical is committed to offering interventional radiologists […]
Cryoablation Eases Pain for Terror Victim

Cryoablation, the process of destroying tissue with ultra-low freezing temperatures, is being used around the world to treat a growing number of clinical indications. In many cases, the driving force behind a novel use of cryoablation is driven not by researchers or physicians, but by the patients themselves. In this blog, we highlight the case […]